📣 Applications are now open for the @helloeacr.bsky.social EACR Molecular Oncology Editorial Fellowship! A great opportunity to gain experience of the editorial and peer-review process and learning more about academic publishing. 📅 Deadline: 11 November 2026 🔗 Apply: www.eacr.org/eacr-molecul...
Molecular Oncology
@moloncology.bsky.social
Open access journal highlighting new discoveries, technical developments and policies in basic, translational, and clinical cancer research. Part of FEBS Press. moloncol.org
To honor the 🎗️ Gynaecological and Urological Cancer Awareness Month, in our latest issue we present a collection of articles featuring pre-clinical research on pre-malignant and malignant conditions of the female reproductive system and urinary tract. 🔓: febs.onlinelibrary.wiley.com/toc/18780261...
📢 We are pleased to announce the Abstract Book of the EACR 2026 Congress is out in a Supplement of the latest issue of Molecular Oncology - affiliated journal of the helloeacr.bsky.social European Association for Cancer Research. 👉Read the abstracts: febs.onlinelibrary.wiley.com/toc/18780261...
🧠 Brain tumours are increasingly being viewed as dynamic ecosystems rather than isolated tumours. Explore the latest issue of Molecular Oncology, featuring new perspectives on brain tumour biology and research. Image credit: Dr Maialen Arrieta. 🔓 febs.onlinelibrary.wiley.com/toc/18780261...
📌One month on from the FEBS Congress we're looking back at the @febspress.bsky.social @helloeacr.bsky.social FEBS- EACR Special Session on "Molecular aspects of cancer" featuring Karin de Visser and Kevin Ryan. 💡Thanks to our speakers and everyone who joined us for this insightful session. 👏
🛎️ Interested in the newest discoveries in cancer metastasis? Consider registering and submitting an abstract for the upcoming #EESMetastasis Symposium! We are thrilled to support the event as media partners and look forward to seeing you there. #metastasis, #cancer, #CancerTherapy, #MeetTheEditor
We're excited to announce that the #EESMetastasis Symposium is now open for registration! Submit your abstract by 18 August 2026: https://s.embl.org/ees26-05-bl Join top scientists and researchers in exploring key concepts of latent metastasis and dissemination of tumour cells. 🧪⚗️🧬
🩸 A novel study from the Kasimir-bauer lab - University Hospital of Essen optimized the analysis of single circulating tumor cells in high-grade serous ovarian cancer to monitor genomic changes during treatment. Congratulations!👏 🔓https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.70193
🔬 A novel study from the Villa lab at the Instituto do Câncer do Estado de São Paulo highlights IGFL2-AS1 as a promising biomarker that could improve the management of cervical adenocarcinoma. Congratulations! 👏 🔓https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.70217
🔬 New research from the Taskén lab, Giusy Di Conza and colleagues show that roginolisib inhibits leukemic cells while preserving key T-cell functions, highlighting its potential as a safer alternative to current PI3K inhibitors. 🔓https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.70203
🧬 In a novel research study, researchers from @arkaitzcarracedo.bsky.social and Mendizabal labs at the @cicbiogune.bsky.social suggest that PTEN loss drives stromal remodeling programs that may help identify clinically aggressive tumors. Congrats! 👏 🔓: febs.onlinelibrary.wiley.com/doi/10.1002/...
🧪 Researchers from the lab of @ayeshashafi.bsky.social from @jeffersonuniv.bsky.social reported how pharmacologic ascorbate (vitamin C) enhances the efficacy of the PARP inhibitor olaparib in castration-resistant prostate cancer. Congratulations! 👏 🔓 febs.onlinelibrary.wiley.com/doi/10.1002/...
🔬 Can we detect pancreatic cancer earlier? Researchers from Ryan lab at @cruk-si.bsky.social report a serum biomarker panel to distinguish pancreatic precursor lesions and early-stage pancreatic ductal adenocarcinoma, supporting early intervention. 🔓 febs.onlinelibrary.wiley.com/doi/10.1002/...
📖 Researchers from the Warsaw University review emerging evidence on large-conductance calcium-activated potassium (BKCa) channels and their role in glioblastoma biology, highlighting the translational challenges of developing BKCa-targeted therapies. 👉 febs.onlinelibrary.wiley.com/doi/10.1002/....
🔬 From the latest issue: The Keiner lab at the @uni-jena.de investigated the role of the chloride cotransporter NKCC1 in glioblastoma as a prognostic marker, suggesting that restoring chloride homeostasis may represent a promising therapeutic strategy. 🔓 febs.onlinelibrary.wiley.com/doi/10.1002/...
🔬 Researchers from the Jan Hahn group combined NIRL laser tissue sampling with lipidomics to identify lipid signatures to distinguish oropharyngeal squamous cell carcinoma from adjacent healthy tissue, supporting rapid molecular diagnostics. Full text: febs.onlinelibrary.wiley.com/doi/10.1002/...
➡️ What drives the anticancer activity of plecstatin in hepatocellular carcinoma? 📖 Researchers from the gregorlab.bsky.social at @imgprague.bsky.social identify plectin as key target of this metallodrug, dissecting its anti-tumor activity. 🔓 Full text: febs.onlinelibrary.wiley.com/doi/full/10....
💡 Can cancer be stopped before it starts? In a Viewpoint, researchers from the @charlesswanton.bsky.social lab discuss cancer interception, to prevent cancer before it develops. Could this be the next frontier in oncology? 🔓 febs.onlinelibrary.wiley.com/doi/10.1002/... #CancerPrevention #EACR
Our latest issue is out! 📣 🔍 We are pleased to present manuscripts showcasing a breadth of topics from insights into tumour evolution, new approaches to intercept cancer before it develops, and novel therapeutic targets in glioblastoma. 🔓 Full issue: febs.onlinelibrary.wiley.com/toc/18780261...
💡This week we highlight a study from the Jochen Utikal lab at @dkfz.bsky.social. 🧬Authors provide new insights into overcoming therapy resistance in melanoma, suggesting ERRFI1 as a potential target for treatment of metastatic melanoma.👏 ➡️ Full text: febs.onlinelibrary.wiley.com/doi/10.1002/...
🔬 Curious about mechanisms driving melanoma progression and metastasis? The Wolnicka-Głubisz lab identified RIPK4 as a regulator of melanoma cell adhesion and metastasis, highlighting its role as a modulator of tumour plasticity. 👏 🔓 Full text: febs.onlinelibrary.wiley.com/doi/10.1002/...
We’re thrilled to reveal the winners of the Molecular Oncology Writing Contest 2026! 🎉 🏆 Muhammad Habiburrahman 🥈 Alyssa Paparella 🥉 Ihsaan Jama ➡️ Read their essays on: febs.onlinelibrary.wiley.com/hub/journal/... 👏 Congratulations! Way to go! #SciComm #FEBS #WritingCommunity #OpenAccess
💡Interested in PD-L1 regulation in melanoma? 📖 A new study from the Annemiek van Spriel and colleagues identifies TSPAN4 as a negative regulator of PD-L1 in melanoma, uncovering a new layer of immune checkpoint regulation. 🔓 Read the full manuscript: febs.onlinelibrary.wiley.com/doi/10.1002/...
FEBS Press
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD-L1 interactome of melanoma cells. TSPAN4 negatively regulates PD-L1 expression and lateral mobility by limit...
febs.onlinelibrary.wiley.com
💡 Join us in congratulating Michalis Gounis @gounismichalis.bsky.social postdoctoral researcher from @turkubioscience.bsky.social for winning the Best Oral Talk FEBS Molecular Oncology prize 🏆at FEBS 2026 Advanced Course on Tumour microenvironment in Fodele, Greece. Well done! 👏 #FEBS #FEBSPress
➡️ May Issue is out ❗ In support of #Melanoma and Skin Cancer Awareness Month, we present a collection of articles focused on melanoma. 📗Cover: Melanoma-secreted peroxidase enables immune escape by binding the NKG2D receptor on NK cells by Hsu-Min Sung et al. - pp 1161-1184. 🔓 buff.ly/TQtHfXU
FEBS Press
<em>Molecular Oncology</em> is an open access FEBS journal covering basic, translational, and clinical cancer research, as well as cancer diagnosis, prevention and care.
buff.ly
📚 New Review for your weekend reading! Liquid biopsy epigenetics: establishing a molecular profile based on cell-free DNA 🔓 buff.ly/4a4AmPZ #Epigenetics #LiquidBiopsy #CellFreeDNA #cfDNA
Are you an early career researcher attending #EACR2026? You're invited to our early career showcase, Cancer Researchers to Watch, taking place 7-8 June! Learn more: 2026.eacr.org/cancer-resea...
Registration is OPEN for the cancer research community to join us for the #EACR2026 Congress! 🥳 Don't miss the opportunity to take advantage of our discounted early registration rate to attend, available until 21 April. 2026.eacr.org
Join us in congratulating Amel Aziba on being selected as the third recipient of an EACR - @moloncology.bsky.social Editorial Fellowship! Learn more about Amel and the Fellowship: magazine.eacr.org/amel-aziba-r...
📘 We are pleased to share our new Thematic issue: European Code Against Cancer – 5th Edition #ECAC5. 🌐ECAC5 provides public health recommendations, and its effective implementation could prevent up to 40% of new cancers in the EU. 👉 Find out more here: febs.onlinelibrary.wiley.com/toc/18780261...
🎗️In support of #WorldCancerDay, Molecular Oncology invites cancer researchers to take part in a writing competition aimed at envisioning a landscape in the year 2050 where #CancerPrevention is as transformative as cancer treatment. ✍ Further details: febs.onlinelibrary.wiley.com/hub/journal/...